NCT07035457View on ClinicalTrials.gov

A Study in Healthy Men to Compare the Amount of Vicadrostat and Empagliflozin in the Blood When Taken Separately and Together

PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

July 2, 2025

Primary Completion Date

August 7, 2025

Study Completion Date

August 15, 2025

Conditions
Healthy
Interventions
DRUG

Vicadrostat

Vicadrostat

DRUG

Jardiance®

Jardiance®

Trial Locations (1)

88397

Humanpharmakologisches Zentrum Biberach, Biberach

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY